Mackenzie Financial
RVMD icon

Mackenzie Financial’s Revolution Medicines RVMD Stock Holding History

Mackenzie Financial’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.96M Buy
15,803
+1,225
+8% +$179K ﹤0.01% 960
2026
Q1 		$1.42M Buy
+14,578
New +$1.47M ﹤0.01% 1015
2025
Q3 		– Sell
-10,961
Closed -$403K – 1822
2025
Q2 		$403K Buy
10,961
+2,640
+32% +$101K ﹤0.01% 1297
2025
Q1 		$294K Buy
8,321
+2,266
+37% +$92K ﹤0.01% 1384
2024
Q4 		$265K Buy
6,055
+885
+17% +$44.7K ﹤0.01% 1435
2024
Q3 		$234K Buy
+5,170
New +$225K ﹤0.01% 1301
2024
Q2 		– Sell
-8,932
Closed -$288K – 1613
2024
Q1 		$288K Buy
8,932
+280
+3% +$8.3K ﹤0.01% 1193
2023
Q4 		$248K Buy
+8,652
New +$208K ﹤0.01% 1238

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Mackenzie Financial's RVMD Position: Q2 2026 in Review

Mackenzie Financial increased its Revolution Medicines (RVMD) stake by 8.4% in Q2 2026, buying an estimated $179K and bringing the position to 15,803 shares worth $2.96M. The position accounts for ﹤0.01% of the portfolio, ranked #960.

Mackenzie Financial first reported a position in RVMD in Q4 2023 and has held it in 8 quarters since. 691 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • Mackenzie Financial held 15,803 shares of Revolution Medicines worth $2.96M as of Q2 2026.
  • Mackenzie Financial bought 1,225 Revolution Medicines shares in Q2 2026, an estimated $179K.
  • Revolution Medicines made up ﹤0.01% of Mackenzie Financial's portfolio in Q2 2026, its #960 holding.
  • Mackenzie Financial first reported a position in Revolution Medicines in Q4 2023 and has held it in 8 quarters since.
  • 691 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.